CDSCO · Drugs Rules Amendment · GSR 506(E) Schedule H2 Expanded: Vaccines, Antimicrobials, Narcotic Drugs & Anticancer Medicines Now Under Stricter Prescription Controls 📅 Gazette Date: 22 June 2026 ⚖️ Effective: 1 July 2027 (Antimicrobials: 1 July 2028) 🏛 Ministry…
17 June, 2022 Central Drugs Standard Control Organization (CDSCO), the central drug regulatory agency of Government of India has issued a new draft gazette notification to notify Schedule H2 drugs and amendment in Rule 96 of Drugs and Cosmetics…
Recent Post
- CDSCO Notifies Final Guidance Document on Medical Device Software (MDSW)
- When a “+” Sign Isn’t Just a Plus
- DCC intends to tighten control on manufacturing and supply of printed packaging materials used for drugs
- High-Alcohol Oral Formulations Move Into Schedule H1
- DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs
